Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis.

Oldham, Justin M; Johnson, Kirk W; Albers, Gesa J; Calamita, Emily; Mah, Jordina; Ghai, Poonam; Hewitt, Richard J; Maher, Toby M; Molyneaux, Philip L; Huang, Michael; Byrne, Adam J

Oldham, Justin M; Johnson, Kirk W; Albers, Gesa J; Calamita, Emily; Mah, Jordina; Ghai, Poonam; Hewitt, Richard J; Maher, Toby M; Molyneaux, Philip L; Huang, Michael; Byrne, Adam J.

Afiliação

Oldham JM; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
Johnson KW; AmMax Bio, Inc., Redwood City, CA, USA.
Albers GJ; National Heart and Lung Institute, Imperial College London, London, UK.
Calamita E; National Heart and Lung Institute, Imperial College London, London, UK.
Mah J; National Heart and Lung Institute, Imperial College London, London, UK.
Ghai P; National Heart and Lung Institute, Imperial College London, London, UK.
Hewitt RJ; National Heart and Lung Institute, Imperial College London, London, UK.
Maher TM; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, UK.
Huang M; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Byrne AJ; National Heart and Lung Institute, Imperial College London, London, UK.

ERJ Open Res ; 9(4)2023 Jul.

Article em En | MEDLINE | ID: mdl-37465557

RESUMO

This study provides the first evidence for a role of airway sCSF1R in IPF https://bit.ly/3KTBrCA.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: ERJ Open Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google